Promising AUD drug trial halted early
Disease control
Terminated
This study tested a new drug, TMP-301, to see if it could help people with alcohol use disorder drink less. The trial was stopped early, so results are limited. About 110 adults were expected to join, but the study did not complete.
Phase: PHASE2 • Sponsor: Tempero Bio, Inc. • Aim: Disease control
Last updated Apr 29, 2026 08:47 UTC